Testing effectiveness (Phase 2)Ended earlyNCT01312935
What this trial is testing
Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Who this might be right for
Percutaneous Coronary InterventionCoronary Artery Disease (CAD)Angioplasty
PolyMedix, Inc. 17